Pfizer
Long
Updated

Updating my PFE trade: the resistance at $38 becomes its support

218
An oral drug from Pfizer causes a similar amount of weight loss as the blockbuster Ozempic injection, made by rival Novo Nordisk, according to results from a phase two clinical trial.
Note
Next resistance: the $41 zone!
Fundamentally, Pfizer Venture Investments has made 141 investments. Their most recent investment was on Jun 7, 2023, when Mozart Therapeutics raised $25M.

snapshot

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.